Stocks/AMC

AMC three-lens brief

Evidence-based stock research on AMC. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$0.93$2.36$3.18

Performance

1W
-7.1%
1M
-1.7%
3M
+5.3%
6M
+116.5%
YTD
+51.3%
1Y
-15.7%
3Y
5Y
AMC · Nightly brief
Inspect

Moved -4.07% yesterday. · Underperforming SPY by 18.1pp over 30 days.

  • Moved -4.07% yesterday.
  • Underperforming SPY by 18.1pp over 30 days.
  • Currently unprofitable on a trailing basis — no P/E multiple available.
  • Analyst mean target $2.80 — 19% above current (6 analysts).

AMC closed at $2.36 (-4.07%) as of 2026-09-11. Market cap: $2.11B. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $2.80 — 19% above current (6 analysts).. Concerns: moved -4.07% yesterday.; underperforming SPY by 18.1pp over 30 days.. Last quarter: Revenue $1.60B, net income -$11.40M, free cash flow $142.60M.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on AMC, not one.

A single reasoning model has blind spots it doesn’t know about. We examine AMCacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/AMC"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath AMC brief"></iframe>